Abstract Library

Welcome to the open-access search for all ENETS abstracts presented at the Annual ENETS Conferences.

Everyone can browse the library to find basic information on abstracts. To get full access to each entry, you will be asked to log in to your myENETS account.

 

Please note:

Participants of the 2025 ENETS Conference enjoy full access to the 2025 conference digital resources through myENETS: the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more.

Log in to myENETS

ENETS Abstract Search

#4608 A complex and rare association of neuroendocrine and endocrine neoplasms: A case report

Introduction: Neuroendocrine tumours (NETs) are sporadic or genetically inherited heterogenous neoplasms affecting multiple sites.

Conference:

Presenting Author: Cerroni L

Authors: Cerroni L, Filice A, Feola T, Sesti F, Vincenzi L,

Keywords: cushing disease, atypical carcinoid, ileal net, genetics,

#4203 The diagnostic role of DWI-MRI for liver metastases of neuroendocrine neoplasms (NENs) in comparison with the functional imaging

Introduction: A combination of morphological and functional imaging plays a crucial role for diagnosis, staging and therapeutic decision for neuroendocrine neoplasms (NENs). Diffusion-weighted imaging (DWI) magnetic resonance imaging (MRI) is emerging as a key imaging technique in the NEN field.

Conference:

Presenting Author: Sesti F

Authors: Feola T, Sesti F, Centello R, Filice A, Pirisino R,

Keywords: MRI, DWI, PET, Liver metastases,

#3207 What role for the interim PET/CT with 68Ga-DOTA peptides in the evaluation of the early response to PRRT?

Introduction: Early evaluation by PET/CT during therapy has an important predictive value of the final response in some tumors (e.g. lymphomas).

Conference: 18th Annual ENETS Concerence (2021)

Presenting Author:

Authors: Durmo R, Cervati V, Finocchiaro D, Filice A, Casali M,

Keywords: PRRT, PET/CT,

#351 Comparison of 68Ga-Somatostatin Analogues, 18F-DOPA and 18F-FDG PET/CT in Patients with Recurrent Medullary Thyroid Carcinoma

Introduction: Early detection of recurrences is a crucial step in the management of patients (pts) with medullary thyroid carcinoma (MTC). Currently, there is growing interest for PET tracers in MTC such as: 18F-FDG (reflecting glucose metabolism), 18F-DOPA (reflecting amine decarboxylation), 68Ga-somatostatin analogues (reflecting somatostatin receptors expression)

Conference:

Presenting Author:

Authors: Treglia G, Castaldi P, Villani M, Filice A, Ambrosini V,

Keywords: PET/CT; medullary thyroid carcinoma; recurrence diagnosis.,

#201 Comparison of 18F-DOPA, 68Ga-Somatostatin Analogues and 18F-FDG PET-CT in Patients with Recurrent Medullary Thyroid Carcinoma

Introduction: Various PET tracers have been proposed for detection of recurrent disease in medullary thyroid carcinoma (MTC). No data have been reported comparing 18F-DOPA and 68Ga-somatostin analogues (SA) in MTC.

Conference: 8th Annual ENETSConcerence (2011)

Presenting Author:

Authors: Treglia G, Castaldi P, Villani M, Filice A, Ambrosini V,

Keywords: positron emission tomography, PET/CT, medullary thyroid carcinoma, neuroendocrine tumors,